Soleno Therapeutics Inc
SLNODelisted May 18, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001484565
Soleno Therapeutics Inc was delisted on May 18, 2026; its insiders filed their last Form 4 on May 18, 2026; 227 institutions reported holding it in 13F filings for Q1 2026, worth $2.09B in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Soleno Therapeutics Inc as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +4 vs. Q3 2022
- Shares held
- 3.03M
- −98.7K (−3.2%) vs. Q3 2022
- Total value
- $6.00M
- +$776.5K (+14.9%) vs. Q3 2022
- New holders
- 6
- 4 more added
- Sold out
- 2
- 8 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLNO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 227 | $2.09B |
| Q4 2025 | 248 | $3.01B |
| Q3 2025 | 240 | $4.41B |
| Q2 2025 | 234 | $4.75B |
| Q1 2025 | 217 | $3.90B |
| Q4 2024 | 166 | $2.29B |
| Q3 2024 | 142 | $2.38B |
| Q2 2024 | 114 | $1.79B |
| Q1 2024 | 98 | $1.52B |
| Q4 2023 | 76 | $1.26B |
| Q3 2023 | 54 | $598.8M |
| Q2 2023 | 23 | $21.8M |
| Q1 2023 | 21 | $7.06M |
| Q4 2022 | 26 | $6.00M |
| Q3 2022 | 22 | $5.23M |
| Q2 2022 | 40 | $8.80M |
| Q1 2022 | 41 | $11.2M |
| Q4 2021 | 39 | $11.8M |
| Q3 2021 | 39 | $27.1M |
| Q2 2021 | 47 | $33.6M |
| Q1 2021 | 63 | $41.2M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Soleno Therapeutics Inc; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Abingworth LLP | 1,201,506 | $2.38M | 0.78% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 604,179 | $1.20M | 0.11% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 422,489 | $836.5K | 0.28% | −1,600−0.4% | Reduced |
| Birchview Capital, LP | 245,127 | $485.0K | 0.34% | 00.0% | Unchanged |
| J. Goldman & Co LP | 112,499 | $222.7K | 0.02% | +67,500+150.0% | Added |
| Worth Venture Partners, LLC | 103,913 | $205.7K | 0.12% | −1,600−1.5% | Reduced |
| Clayton Partners LLC | 92,772 | $183.7K | 0.17% | −7,228−7.2% | Reduced |
| Renaissance Technologies LLC | 49,754 | $99.0K | 0.00% | +4,800+10.7% | Added |
| Vanguard Group Inc | 49,939 | $98.9K | 0.00% | −71,147−58.8% | Reduced |
| Millennium Management LLC | 45,876 | $91.0K | 0.00% | +45,876 | New |
| Geode Capital Management, LLC | 32,556 | $64.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 19,932 | $39.5K | 0.01% | +19,932 | New |
| State Street Corp | 15,448 | $30.6K | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 12,570 | $24.9K | 0.00% | +12,570 | New |
| Susquehanna International Group, LLP | 11,545 | $22.9K | 0.00% | +11,545 | New |
| Tower Research Capital LLC (TRC) | 7,952 | $16.0K | 0.00% | +7,090+822.5% | Added |
| Bollard Group LLC | 2,288 | $5.00K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 342 | $677 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 243 | $481 | 0.00% | −115−32.1% | Reduced |
| Citigroup Inc | 100 | $198 | 0.00% | +100 | New |
| Wells Fargo & Company | 38 | $75 | 0.00% | +1+2.7% | Added |
| Morgan Stanley | 14 | $28 | 0.00% | −635−97.8% | Reduced |
| Bank of America Corp | 1 | $2 | 0.00% | +1 | New |
| JPMorgan Chase & Co | 6 | $0 | 0.00% | −4−40.0% | Reduced |
| Royal Bank of Canada | 6 | $0 | 0.00% | −3−33.3% | Reduced |
| Advisor Group Holdings, Inc. | 71 | $0 | 0.00% | 00.0% | Unchanged |
| Granite Point Capital Management, L.P. | 0 | $0 | 0.00% | −176,456−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −9,333−100.0% | Sold out |